Development of Imiqualine compounds with enhanced activity against cutaneous leishmaniasis.
Cutaneous leishmaniasis (CL) is a neglected tropical disease still inflicting a high number of individuals worldwide with a rising prevalence in the Eastern Mediterranean region. Current treatment options remain hindered by substantial toxicity, high relapse rates, and emergence of drug resistance. Imiqualines, a famil...